Alpine Global Management’s LumiraDx Limited Warrant LMDXW Stock Holding History

Alpine Global Management’s Portfolio LMDXW Stock Details LMDXW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-64,024	Closed	-$7K	–	622
2022 Q3	$7K	Sell	64,024 -25,488	-28%	-$8.47K	﹤0.01%	210
2022 Q2	$81K	Sell	89,512 -15,737	-15%	-$13.6K	0.02%	153
2022 Q1	$85	Hold	105,249	–	–	0.02%	293
2021 Q4	$151K	Sell	105,249 -84,925	-45%	-$137K	0.02%	503
2021 Q3	$221K	Buy	+190,174	New	+$221K	0.05%	199

Other funds holding LMDXW

CVS Health Woonsocket, Rhode Island $212M AUM 19.39% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return

MCM

Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Covalent Partners Concord, Massachusetts $17.6M AUM 2.91% 1-Year Est. Return

Alpine Global Management's LMDXW Position: Q4 2022 in Review

Alpine Global Management sold out of LumiraDx Limited Warrant (LMDXW) in Q4 2022, closing a stake of 64,024 shares — an estimated $7K sold.

Alpine Global Management first reported a position in LMDXW in Q3 2021 and held it in 5 quarters. The position peaked at $221K in Q3 2021. 17 funds tracked by Wall St. Rank hold LMDXW as of Q4 2022.

Alpine Global Management reported no remaining LumiraDx Limited Warrant position as of Q4 2022 after selling out during the quarter.
Alpine Global Management sold 64,024 LumiraDx Limited Warrant shares in Q4 2022, an estimated $7K.
Alpine Global Management first reported a position in LumiraDx Limited Warrant in Q3 2021 and held it in 5 quarters.
Alpine Global Management's LumiraDx Limited Warrant position peaked at $221K in Q3 2021.
17 funds tracked by Wall St. Rank held LumiraDx Limited Warrant as of Q4 2022.

Based on Alpine Global Management's 13F filing for Q4 2022, filed 14 Feb 2023.